Patent Assignment
Reel/Frame 046244/0794
Assignment of Assignor's Interest
Recorded: 2018-05-25
Pages: 5
Assignor
ACTELION PHARMACEUTICALS LTD
Executed: 2017-05-09
Assignee
IDORSIA PHARMACEUTICALS LTD
HEGENHEIMERMATTWEG 91, ALLSCHWIL, CH-4123, SWITZERLAND
Covered Property
(1)
Crystalline Salt Form of (S)-(2-(6-Chloro-7-Methyl-1H-Benzo[D]Imidazol-2-Yl)-2-Methylpyrrolidin-1-Yl)(5-Methoxy-2-(2H-1,2,3-Triazol-2-Yl)Phenyl)Methanone as Orexin Receptor Antagonist
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 26, 2018
From: BOSS, CHRISTOPH; BROTSCHI, CHRISTINE; GUDE, MARKUS; HEIDMANN, BIBIA
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 045351/0787 →
Patent Security Agreement
Jun 25, 2026
From: IDORSIA PHARMACEUTICALS LTD
To: BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
Reel/Frame 076038/0461 →